Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

MRNA

Moderna Inc

Mar 13 • 04:00PM ET

34.30

Dollar change -0.71
Percentage change -2.03	%

Healthcare • Biotechnology • USA • NASD

Peers: PFE BNTX NVAX JNJ AZN GSK MRK SNY LLY REGN

| Held by: VTI VOO VO SPY IVV RSP XBI VOT VUG XLV

Scroll to Statements

Index	S&P 500	P/E	-	EPS (ttm)	-9.28	Insider Own	11.44%	Shs Outstand	386.00M	Perf Week	0.00%
Market Cap	13.23B	Forward P/E	-	EPS next Y	-7.82	Insider Trans	0.43%	Shs Float	341.66M	Perf Month	10.90%
Income	-3561.00M	PEG	-	EPS next Q	-3.09	Inst Own	70.78%	Short Float	13.19%	Perf Quarter	-24.86%
Sales	3.24B	P/S	4.09	EPS this Y	-8.92%	Inst Trans	7.24%	Short Ratio	3.85	Perf Half Y	-56.74%
Book/sh	28.24	P/B	1.21	EPS next Y	22.66%	ROA	-21.87%	Short Interest	45.06M	Perf Year	-69.37%
Cash/sh	18.21	P/C	1.88	EPS next 5Y	14.62%	ROE	-28.77%	52W Range	29.25 - 170.47	Perf YTD	-17.51%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-42.94%	ROI	-30.67%	52W High	-79.88%	Beta	2.12
Dividend TTM	-	Quick Ratio	3.62	Sales past 5Y	662.63%	Gross Margin	48.92%	52W Low	17.26%	ATR (14)	2.75
Dividend Ex-Date	-	Current Ratio	3.67	EPS Y/Y TTM	25.00%	Oper. Margin	-121.91%	RSI (14)	49.34	Volatility	8.98% 7.98%
Employees	5800	Debt/Eq	0.07	Sales Y/Y TTM	-52.75%	Profit Margin	-110.04%	Recom	2.89	Target Price	51.40
Option/Short	Yes / Yes	LT Debt/Eq	0.07	EPS Q/Q	-629.50%	Payout	-	Rel Volume	0.80	Prev Close	35.01
Sales Surprise	2.46%	EPS Surprise	-8.57%	Sales Q/Q	-65.54%	Earnings	Feb 14 BMO	Avg Volume	11.71M	Price	34.30
SMA20	1.87%	SMA50	-5.64%	SMA200	-51.32%	Trades		Volume	9,418,936	Change	-2.03%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-13-25	Initiated	Citigroup	Neutral	$40
Feb-18-25	Downgrade	Barclays	Overweight → Equal Weight	$111 → $45
Jan-29-25	Downgrade	Goldman	Buy → Neutral	$99 → $51
Dec-18-24	Downgrade	Argus	Buy → Hold
Dec-10-24	Resumed	BofA Securities	Underperform	$41
Nov-19-24	Initiated	Berenberg	Hold	$42
Nov-18-24	Upgrade	HSBC Securities	Hold → Buy	$58
Nov-15-24	Initiated	Wolfe Research	Underperform	$40
Oct-17-24	Initiated	Bernstein	Mkt Perform	$55
Sep-13-24	Downgrade	Oppenheimer	Outperform → Perform
Sep-13-24	Downgrade	JP Morgan	Neutral → Underweight	$88 → $70
Sep-13-24	Downgrade	Jefferies	Buy → Hold	$120 → $65
Aug-28-24	Upgrade	HSBC Securities	Reduce → Hold	$82
Aug-07-24	Upgrade	Deutsche Bank	Sell → Hold	$85 → $80
Aug-05-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$125 → $90
Feb-26-24	Downgrade	HSBC Securities	Hold → Reduce	$75 → $86
Jan-02-24	Upgrade	Oppenheimer	Perform → Outperform	$142
Nov-29-23	Initiated	Canaccord Genuity	Hold	$82
Nov-03-23	Upgrade	HSBC Securities	Reduce → Hold	$89 → $69
Nov-02-23	Downgrade	Deutsche Bank	Hold → Sell	$125 → $60

Show Previous Ratings

Mar-13-25 01:03PM	Is Moderna Stock A Sell As RFK Jr. Reportedly Mulls A Massive Funding Pull? (Investor's Business Daily)
11:34AM	Citi says SMid biotechs alternative to large caps as it starts coverage (Investing.com)
Mar-12-25 05:05AM	3 Reasons MRNA is Risky and 1 Stock to Buy Instead (StockStory)
Mar-11-25 05:03AM	Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks (StockStory) -6.12%
Mar-09-25 03:00AM	3 CEOs Just Spent Millions Buying Their Beaten-Down Stock (Barrons.com)
11:21AM	Loading…
Mar-08-25 11:21AM	CDC plans study into potential vaccines, autism connections, Reuters reports (TipRanks)
Mar-07-25 04:04PM	Why Moderna Stock Has Surged 15% This Week Despite Mixed News (Investor's Business Daily)
Mar-06-25 07:55AM	Why Moderna, Inc. (MRNA) Went Up on Wednesday (Insider Monkey)
Mar-05-25 05:59PM	Why Moderna Stock Zoomed Nearly 16% Higher on Wednesday (Motley Fool) +15.94%
04:47PM	S&P 500 Gains and Losses Today: Moderna Stock Pops as Execs Buy Shares, Express Cancer Vaccine Optimism (Investopedia)
04:00PM	The Dow surges 500 points as Trump hands out some tariff relief (Quartz)
01:06PM	Why Moderna (MRNA) Stock Is Rallying Today (Insider Monkey)
01:05PM	Moderna Scores Legal Victory Over Pfizer, BioNTech in Patent Dispute (GuruFocus.com)
12:19PM	Moderna, Alibaba & Tencent, BlackRock: Market Minute (Yahoo Finance Video)
10:02AM	German court rules Pfizer, BioNTech violated Moderna's COVID-19 vaccine patent (Reuters)
09:35AM	Loading…
09:35AM	Moderna Stock Is Surging. The CEO Bought $5 Million of Shares. (Barrons.com)
Mar-04-25 04:10AM	Coatue's Philippe Laffont Just Bought Shares of This Beaten-Down Growth Stock That Wall Street Predicts Will Soar 80% (Motley Fool)
04:03AM	Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4 (StockStory)
Mar-01-25 10:35AM	Moderna receives MHRA marketing authorization for RSV vaccine (TipRanks)
Feb-28-25 10:30AM	Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine (ACCESSWIRE)
08:02AM	1 Healthcare Stock to Own for Decades and 2 to Ignore (StockStory)
03:15AM	3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%. (Motley Fool)
Feb-27-25 04:37PM	Moderna Stock Slumps 7% On A Surprise Twist In The RFK Jr. Saga (Investor's Business Daily) -7.42%
04:29PM	These Stocks Moved the Most Today: Nvidia, Super Micro, Snowflake, Moderna, Tesla, Salesforce, Vistra, and More (Barrons.com)
02:30PM	Moderna Tumbles As RFK Jr. Reportedly Mulls Pulling $590 Million In Bird Flu Funds (Investor's Business Daily)
11:55AM	These Stocks Are Moving the Most Today: Nvidia, Super Micro, Snowflake, Moderna, Tesla, Salesforce, Vistra, and More (Barrons.com)
11:48AM	Health dept. reviewing bird flu vaccine deal with Moderna: RPT (Yahoo Finance Video)
10:05AM	Can Moderna's Aggressive Cost Cuts Help Turn Things Around for Its Stock? (Motley Fool)
09:34AM	Trump Team Weighs Pulling Funds for Moderna Bird Flu Vaccine (Bloomberg)
08:42AM	Moderna's bird flu vaccine has a problem (Quartz)
08:33AM	Loading…
08:33AM	Moderna Stock Falls on Report HHS Is Reviewing Bird Flu Vaccine Contract (Barrons.com)
08:08AM	Trump administration may cancel Moderna's bird flu vaccine (Quartz)
Feb-26-25 07:22PM	Moderna Shares Fall on Report HHS Is Reviewing Bird Flu Vaccine Contract (Barrons.com)
11:50AM	Moderna, Inc. (MRNA): A Bull Case Theory (Insider Monkey)
11:01AM	Moderna, Inc. (MRNA): Among the Best Vaccine Stocks to Buy According to Hedge Funds (Insider Monkey)
Feb-25-25 07:00AM	Moderna to Present at Upcoming Conferences in March 2025 (ACCESS Newswire)
Feb-24-25 09:15AM	Moderna (MRNA) International Revenue Performance Explored (Zacks)
Feb-22-25 12:37AM	Why Moderna Inc. (MRNA) Surged On Friday? (Insider Monkey)
Feb-21-25 05:27PM	Moderna and Other Vaccine Stocks Climb Amid Concerns About Coronavirus Study in China (Investopedia) +5.34%
Feb-20-25 03:22AM	Will Moderna Stock Drop to $25? 1 Wall Street Analyst Thinks So. (Motley Fool) -6.04%
Feb-19-25 08:53AM	Bausch and Lomb's dealmaking CEO Brent Saunders: No deal for company is imminent (Yahoo Finance)
08:18AM	Why Moderna (MRNA) Went Up on Tuesday? (Insider Monkey)
02:43AM	Challenges mount for vaccine makers (Pharma Voice)
Feb-18-25 02:22PM	Why Moderna (MRNA) Stock Is Up Today (StockStory) +8.37%
01:09PM	Moderna Downgraded by Barclays as Policy Risks and Weak Revenue Weigh on Outlook (GuruFocus.com)
11:30AM	Moderna has limited upside: Barclays (Investing.com)
08:00AM	Is Moderna Stock A Buy As Its CEO Fends Off RFK Jr. Concerns? (Investor's Business Daily)
Feb-17-25 09:00PM	First Cows, Now Cats. Is Bird Flu Coming for Humans Next? (The Wall Street Journal)
04:26AM	Moderna reports decline in Q4 2024 revenue (Pharmaceutical Technology)
Feb-15-25 02:04AM	Moderna Inc (MRNA) Q4 2024 Earnings Call Highlights: Navigating Challenges and Strategic Shifts (GuruFocus.com)
12:10AM	Q4 2024 Moderna Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-14-25 06:07PM	A lot of concern around Moderna over next year or so, says Jefferies Michael Yee (CNBC TV) +8.37%
05:04PM	These Stocks Moved the Most Today: Super Micro, Coinbase, SoundHound, Airbnb, Moderna, Intel, DaVita, GameStop, and More (Barrons.com)
04:17PM	Moderna Stock Reverses As CEO Stephane Bancel Deflects Concerns Over RFK Jr. (Investor's Business Daily)
03:26PM	These Stocks Are Moving the Most Today: Super Micro, Coinbase, SoundHound, Airbnb, Moderna, Intel, DaVita, GameStop, and More (Barrons.com)
02:55PM	Moderna Reports Another Quarterly Loss (Bloomberg)
01:45PM	Moderna (MRNA) Q4 2024 Earnings Call Transcript (Motley Fool)
01:23PM	Modernas Shot Sales, Canceled Contract Lead to Another Loss (Bloomberg)
11:22AM	AI and robotics, Moderna earnings, GameStop: Market Minute (Yahoo Finance Video)
11:07AM	Moderna Posts Wider-Than-Expected Q4 Loss, 2025 Sales Outlook Disappoints (Investopedia)
11:07AM	Moderna Posts Wider-Than-Expected Q4 Loss, 2025 Sales Guide Disappoints (Investopedia)
10:13AM	Moderna's Quarterly Loss Widens, Cost Cuts Planned as COVID-19 Vaccine Demand Falls (GuruFocus.com)
09:51AM	Moderna's Q4 loss: Can the pharma giant get to profitability? (Yahoo Finance Video)
09:09AM	Retail sales, reciprocal tariffs, Coinbase earnings: 3 Things (Yahoo Finance Video)
09:02AM	Moderna Stock Falls on Earnings Report. The Results Reaffirm a Grim Picture for Vaccine Maker. (Barrons.com)
08:48AM	Moderna Adds Onto Its 94% Dive With Light Fourth-Quarter Profit (Investor's Business Daily)
08:04AM	Moderna Struggles With Declining Q4 COVID Vaccine Sales, Stock Slides (Benzinga)
07:45AM	Moderna (MRNA) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:43AM	Moderna stock down premarket on mixed 2024 earnings (Yahoo Finance)
06:40AM	Moderna: Q4 Earnings Snapshot (Associated Press Finance)
06:38AM	Modernas Results Reaffirm a Grim Picture for Vaccine Maker (Barrons.com)
06:35AM	Modernas (NASDAQ:MRNA) Q4 Earnings Results: Revenue In Line With Expectations But Full-Year Sales Guidance Misses Expectations Significantly (StockStory)
06:34AM	Moderna posts bigger loss than expected as vaccine maker scales down manufacturing (Reuters)
06:30AM	Will Moderna's Retained 2025 Outlook Bolster Its Depressed Shares? (Investor's Business Daily)
06:28AM	Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates (ACCESSWIRE)
Feb-13-25 07:00PM	Moderna earnings, retail sales data, FedSpeak: What to Watch (Yahoo Finance Video)
05:56PM	Informatica CEO on earnings, top trading themes: Asking for a Trend (Yahoo Finance Video)
04:14PM	It's Official: The Senate Will Let Robert F. Kennedy Jr. 'Go Wild' On Health Care (Investor's Business Daily)
08:00AM	Moderna (MRNA) Q4 Earnings Report Preview: What To Look For (StockStory)
Feb-12-25 01:25PM	RFK Jr. Confirmation Looms. How Kennedy Could 'Go Wild' On Health Care. (Investor's Business Daily)
Feb-11-25 09:15AM	Insights Into Moderna (MRNA) Q4: Wall Street Projections for Key Metrics (Zacks)
Feb-10-25 11:57PM	Q3 2024 Roivant Sciences Ltd Earnings Call (Thomson Reuters StreetEvents)
10:32AM	Pharma Companies Turn to AI to Speed Up Drug Development, But Hit Hurdles (The Wall Street Journal)
08:25AM	Why Moderna Inc. (MRNA) Crashed Last Week (Insider Monkey)
Feb-09-25 11:15AM	2 Biotech Stocks to Buy Hand Over Fist in February (Motley Fool)
09:30AM	1 Stock to Buy, 1 Stock to Sell This Week: Robinhood, Moderna (Investing.com)
Feb-08-25 11:57AM	3 Beaten-Down Stocks That Aren't Worth Buying on the Dip (Motley Fool)
09:16AM	Why Moderna, Inc. (MRNA) Is Among the Best Healthcare Stocks To Buy According to Analysts (Insider Monkey)
Feb-07-25 10:00AM	Moderna (MRNA) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release (Zacks)
Feb-06-25 09:45AM	3 Top AI-Powered Biotech Stocks to Buy in February (Motley Fool)
08:30AM	Is Moderna Stock A Sell With Robert F. Kennedy Eyeing The Lead Role At HHS? (Investor's Business Daily)
Feb-05-25 07:42AM	Why Moderna, Inc. (MRNA) Went Down on Tuesday (Insider Monkey)
Feb-04-25 04:13PM	RFK Jr. Clears A Key Hurdle To Head Up HHS. Why His Nomination Is A Biotech Black Box. (Investor's Business Daily) -6.51%
02:34PM	RFK Jr. Clears Committee Vote, Is On Track to Become Health Secretary (The Wall Street Journal)
01:48PM	Drug Stocks Stumble as RFK Jr.s HHS Nomination Moves Forward to a Senate Vote (Barrons.com)
11:55AM	Health, pharma stocks fall as RFK Jr. clears crucial vote (Yahoo Finance Video)
08:53AM	Why Moderna Inc. (MRNA) Crashed on Monday (Insider Monkey)
Feb-03-25 04:42PM	S&P 500 Gains and Losses Today: Index Falls Following Tariff Announcements (Investopedia) -7.28%
Feb-02-25 08:33AM	Why Are Analysts Bullish on Moderna, Inc. (MRNA) Now? (Insider Monkey)
Jan-30-25 08:03AM	Shionogis RSV antiviral reduces viral load in Phase II human challenge trial (Clinical Trials Arena)

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Bancel Stephane	Chief Executive Officer	Mar 03 '25	Buy	31.22	160,314	5,004,318	9,210,686	Mar 04 04:27 PM
SAGAN PAUL	Director	Mar 03 '25	Buy	31.76	31,620	1,004,251	312,027	Mar 04 04:24 PM
Klinger Shannon Thyme	Chief Legal Officer	Dec 09 '24	Sale	44.68	529	23,637	20,446	Dec 10 04:08 PM
Klinger Shannon Thyme	Officer	Dec 09 '24	Proposed Sale	44.68	529	23,637		Dec 09 03:18 PM
Klinger Shannon Thyme	Chief Legal Officer	Dec 03 '24	Sale	43.30	112	4,849	19,837	Dec 04 05:11 PM
Hoge Stephen	President	Dec 03 '24	Sale	43.30	314	13,595	1,443,904	Dec 04 05:08 PM
Klinger Shannon Thyme	Officer	Dec 03 '24	Proposed Sale	43.30	112	4,849		Dec 03 04:11 PM
Hoge Stephen	Officer	Dec 03 '24	Proposed Sale	43.30	314	13,595		Dec 03 03:23 PM
Mock James M	Chief Financial Officer	Nov 29 '24	Sale	42.79	1,420	60,761	11,066	Dec 02 04:26 PM
Klinger Shannon Thyme	Chief Legal Officer	Nov 29 '24	Sale	42.79	1,418	60,675	19,717	Dec 02 04:19 PM
Hoge Stephen	President	Nov 29 '24	Sale	42.79	291	12,452	1,443,567	Dec 02 04:15 PM
Hoge Stephen	Officer	Nov 29 '24	Proposed Sale	42.79	291	12,452		Nov 29 03:54 PM
Klinger Shannon Thyme	Officer	Nov 29 '24	Proposed Sale	42.79	1,418	60,675		Nov 29 03:49 PM
Mock James M	Officer	Nov 29 '24	Proposed Sale	42.79	1,420	60,761		Nov 29 03:35 PM
Hoge Stephen	President	Nov 11 '24	Sale	46.10	277	12,771	1,443,248	Nov 12 04:14 PM
Hoge Stephen	Officer	Nov 11 '24	Proposed Sale	46.10	277	12,771		Nov 12 09:27 AM
Mock James M	Chief Financial Officer	Oct 07 '24	Sale	60.12	715	42,986	9,505	Oct 08 04:19 PM
Klinger Shannon Thyme	Chief Legal Officer	Sep 09 '24	Sale	73.57	551	40,539	18,154	Sep 10 04:15 PM
Klinger Shannon Thyme	Officer	Sep 09 '24	Proposed Sale	73.57	551	40,539		Sep 09 03:29 PM
Klinger Shannon Thyme	Chief Legal Officer	Sep 03 '24	Sale	76.99	114	8,777	17,566	Sep 04 05:42 PM
Hoge Stephen	President	Sep 03 '24	Sale	76.99	318	24,483	1,443,002	Sep 04 04:26 PM
Klinger Shannon Thyme	Officer	Sep 03 '24	Proposed Sale	76.99	114	8,777		Sep 03 03:58 PM
Hoge Stephen	Officer	Sep 03 '24	Proposed Sale	76.99	318	24,482		Sep 03 03:42 PM
Mock James M	Chief Financial Officer	Aug 29 '24	Sale	78.03	162	12,640	8,767	Aug 30 04:37 PM
Klinger Shannon Thyme	Chief Legal Officer	Aug 29 '24	Sale	78.03	162	12,640	17,447	Aug 30 04:34 PM
Hoge Stephen	President	Aug 29 '24	Sale	78.03	300	23,408	1,442,668	Aug 30 04:32 PM
Mock James M	Chief Financial Officer	Aug 28 '24	Sale	79.39	1,321	104,881	8,600	Aug 29 04:45 PM
Klinger Shannon Thyme	Chief Legal Officer	Aug 28 '24	Sale	79.39	1,319	104,722	17,280	Aug 29 04:03 PM
Klinger Shannon Thyme	Officer	Aug 29 '24	Proposed Sale	78.03	162	12,640		Aug 29 03:52 PM
Mock James M	Officer	Aug 29 '24	Proposed Sale	78.03	162	12,640		Aug 29 03:43 PM
Hoge Stephen	Officer	Aug 29 '24	Proposed Sale	78.03	300	23,408		Aug 29 03:38 PM
Mock James M	Officer	Aug 28 '24	Proposed Sale	79.39	1,321	104,881		Aug 28 04:47 PM
Klinger Shannon Thyme	Officer	Aug 28 '24	Proposed Sale	79.39	1,319	104,722		Aug 28 04:30 PM
Hoge Stephen	President	Aug 12 '24	Sale	84.10	254	21,363	1,442,357	Aug 13 04:33 PM
Hoge Stephen	Officer	Aug 12 '24	Proposed Sale	84.10	254	21,363		Aug 12 04:05 PM
AFEYAN NOUBAR	Director	Jul 31 '24	Sale	119.96	15,000	1,799,443	2,224,015	Aug 02 07:00 PM
NOUBAR B AFEYAN	Director	Jul 31 '24	Proposed Sale	118.84	15,000	1,782,600		Jul 31 04:18 PM
AFEYAN NOUBAR	Director	Jul 24 '24	Sale	117.80	15,000	1,766,972	2,239,015	Jul 26 07:00 PM
AFEYAN NOUBAR	Director	Jul 17 '24	Sale	122.84	15,000	1,842,651	2,254,015	Jul 19 07:00 PM
Hoge Stephen	President	Jul 15 '24	Sale	121.12	15,000	1,816,800	1,442,089	Jul 16 04:08 PM
AFEYAN NOUBAR	Director	Jul 10 '24	Sale	117.08	15,000	1,756,177	2,269,015	Jul 12 07:00 PM
Mock James M	Chief Financial Officer	Jul 08 '24	Sale	118.24	689	81,465	7,269	Jul 09 04:34 PM
AFEYAN NOUBAR	Director	Jun 26 '24	Sale	127.22	15,000	1,908,293	2,284,015	Jun 28 07:00 PM
AFEYAN NOUBAR	Director	Jun 18 '24	Sale	133.57	15,000	2,003,561	2,299,015	Jun 21 07:00 PM
Hoge Stephen	President	Jun 17 '24	Sale	138.16	15,000	2,072,400	1,457,089	Jun 18 04:05 PM
AFEYAN NOUBAR	Director	Jun 12 '24	Sale	147.20	15,000	2,208,071	2,314,015	Jun 14 07:00 PM
AFEYAN NOUBAR	Director	Jun 11 '24	Sale	148.34	202,832	30,087,339	1,528,557	Jun 11 07:01 PM
Klinger Shannon Thyme	Chief Legal Officer	Jun 10 '24	Sale	148.09	5,178	766,785	15,947	Jun 11 04:05 PM
AFEYAN NOUBAR	Director	Jun 05 '24	Sale	151.25	15,000	2,268,804	1,946,931	Jun 07 07:00 PM
Mock James M	Chief Financial Officer	Jun 03 '24	Sale	140.72	691	97,237	6,506	Jun 04 05:27 PM
Hoge Stephen	President	Jun 03 '24	Sale	140.72	339	47,704	1,472,089	Jun 04 05:20 PM
Klinger Shannon Thyme	Chief Legal Officer	Jun 03 '24	Sale	140.72	122	17,168	10,878	Jun 04 05:12 PM
AFEYAN NOUBAR	Director	May 29 '24	Sale	145.08	20,000	2,901,585	1,961,931	May 31 07:00 PM
Mock James M	Chief Financial Officer	May 29 '24	Sale	144.50	183	26,444	5,871	May 30 04:36 PM
Klinger Shannon Thyme	Chief Legal Officer	May 29 '24	Sale	144.50	183	26,444	10,768	May 30 04:27 PM
Hoge Stephen	President	May 29 '24	Sale	144.50	341	49,276	1,471,777	May 30 04:14 PM
Mock James M	Chief Financial Officer	May 28 '24	Sale	162.47	648	105,283	5,726	May 29 04:16 PM
Klinger Shannon Thyme	Chief Legal Officer	May 28 '24	Sale	162.47	1,296	210,566	10,623	May 29 04:12 PM
AFEYAN NOUBAR	Director	May 22 '24	Sale	157.57	15,000	2,363,556	1,981,931	May 24 07:00 PM
AFEYAN NOUBAR	Director	May 15 '24	Sale	127.32	15,000	1,909,863	1,996,931	May 17 07:00 PM
Hoge Stephen	President	May 15 '24	Sale	127.49	15,000	1,912,350	1,471,508	May 17 04:04 PM
Hoge Stephen	President	May 10 '24	Sale	120.96	255	30,844	1,486,508	May 13 04:03 PM
AFEYAN NOUBAR	Director	May 08 '24	Sale	121.68	15,000	1,825,220	2,011,931	May 10 07:00 PM
AFEYAN NOUBAR	Director	May 01 '24	Sale	110.92	15,000	1,663,855	2,026,931	May 03 07:00 PM
AFEYAN NOUBAR	Director	Apr 24 '24	Sale	108.32	15,000	1,624,836	2,041,931	Apr 26 07:00 PM
AFEYAN NOUBAR	Director	Apr 17 '24	Sale	103.38	15,000	1,550,703	2,056,931	Apr 19 07:00 PM
Hoge Stephen	President	Apr 15 '24	Sale	105.02	15,000	1,575,300	1,486,241	Apr 16 04:23 PM
AFEYAN NOUBAR	Director	Apr 10 '24	Sale	107.12	15,000	1,606,865	2,071,931	Apr 12 07:00 PM
Mock James M	Chief Financial Officer	Apr 08 '24	Sale	101.93	705	71,859	5,048	Apr 09 04:09 PM
AFEYAN NOUBAR	Director	Apr 03 '24	Sale	101.68	15,000	1,525,268	2,086,931	Apr 05 07:00 PM
AFEYAN NOUBAR	Director	Mar 27 '24	Sale	109.06	15,000	1,635,864	2,101,931	Mar 29 07:00 PM
AFEYAN NOUBAR	Director	Mar 20 '24	Sale	102.39	15,000	1,535,820	2,116,931	Mar 22 07:00 PM
Hoge Stephen	President	Mar 15 '24	Sale	103.17	15,000	1,547,550	1,501,241	Mar 19 04:39 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MRNA

Moderna Inc

Upgrade your FINVIZ experience